Tandem Diabetes Care (TNDM) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to 0.15.
- Tandem Diabetes Care's Equity Ratio fell 3875.13% to 0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15, marking a year-over-year decrease of 3875.13%. This contributed to the annual value of 0.27 for FY2024, which is 1741.29% down from last year.
- Per Tandem Diabetes Care's latest filing, its Equity Ratio stood at 0.15 for Q3 2025, which was down 3875.13% from 0.15 recorded in Q2 2025.
- In the past 5 years, Tandem Diabetes Care's Equity Ratio registered a high of 0.48 during Q4 2021, and its lowest value of 0.15 during Q3 2025.
- Over the past 5 years, Tandem Diabetes Care's median Equity Ratio value was 0.35 (recorded in 2023), while the average stood at 0.33.
- As far as peak fluctuations go, Tandem Diabetes Care's Equity Ratio surged by 367.8% in 2022, and later crashed by 3899.15% in 2025.
- Tandem Diabetes Care's Equity Ratio (Quarter) stood at 0.48 in 2021, then dropped by 12.67% to 0.42 in 2022, then dropped by 21.22% to 0.33 in 2023, then decreased by 17.41% to 0.27 in 2024, then plummeted by 44.09% to 0.15 in 2025.
- Its Equity Ratio was 0.15 in Q3 2025, compared to 0.15 in Q2 2025 and 0.17 in Q1 2025.